Tirzepatide 10mg

Tirzepatide is a synthetic 39-amino-acid lipidated peptide and dual agonist of the GLP-1 and GIP receptors. Engineered from the GIP backbone with Aib substitutions at positions 2 and 13 and a C20 fatty-diacid acylation on Lys-20, it is classified as a "twincretin" in research literature. Labs studying metabolic regulation, pancreatic beta-cell function, or energy homeostasis use tirzepatide as a reference compound for dual incretin receptor research. Its balanced affinity for both GIPR and GLP-1R makes it valuable for comparing receptor cross-talk, biased agonism, and glucose-dependent insulin secretion in engineered cell lines. Our tirzepatide is synthesized to >99.6% purity and analyzed by HPLC and ESI-MS. The 10 mg vial is sufficient for extended in vitro protocols. Store at −20°C; protect from light. FAQs What is tirzepatide? Tirzepatide is a 39-amino-acid dual GLP-1/GIP receptor agonist studied in laboratory models of metabolic regulation, insulin secretion, and energy homeostasis. Where can I buy tirzepatide for research? You can buy research-grade tirzepatide from Haelo Labs. Our 10 mg vials are third-party tested with HPLC and mass spectrometry verification. How does tirzepatide differ from retatrutide? Tirzepatide is a dual GLP-1/GIP agonist, while retatrutide adds glucagon receptor activation for a triple agonist profile. Researchers compare both to study incremental metabolic effects.